REGENXBIO Inc. (RGNX) Free cash flow 2016–2025
REGENXBIO Inc. (RGNX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$126.4MFY2025 · since FY2016: -$56.7M → -$126.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$126.4M | +28.0% |
| FY2024 | -$175.6M | +23.1% |
| FY2023 | -$228.4M | +4.1% |
| FY2022 | -$238.2M | -276.8% |
| FY2021 | $134.7M | +266.4% |
| FY2020 | -$80.9M | +32.2% |
| FY2019 | -$119.4M | -230.7% |
| FY2018 | $91.4M | +240.2% |
| FY2017 | -$65.2M | -14.9% |
| FY2016 | -$56.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice